CHOP is superior to CNOP in elderly patients with aggressive lymphoma while outcome is unaffected by filgrastim treatment: results of a Nordic Lymphoma Group randomized trial

E Osby, H Hagberg, S Kvaloy, L Teerenhovi, Harald Anderson, Eva Cavallin-Ståhl, H Holte, J Myhre, H Pertovaara, M Bjorkholm

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'CHOP is superior to CNOP in elderly patients with aggressive lymphoma while outcome is unaffected by filgrastim treatment: results of a Nordic Lymphoma Group randomized trial'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds